Skip to content
x.com· @ · X·· 2026-04-22Score60
Body

Happening now at #AACR26, UF Health Cancer Institute researchers are presenting on dual targeting of IKKβ and NR4A1 for AML therapy. Read the abstract: https://t.co/wTVMqUFAwF https://t.co/Aj6kgY2SxC

Heat 3 · 3 likes · 0 replies · 0 reposts

Source: x.com · x.com

CBACBA Frontier Insights (CFI)Chinese Biopharmaceutical Association (CBA)www.cba-usa.org